About Neurofluidics

What does Neurofluidics do?

Neurofluidics is a provider of organs-on-chip and microfluidic medical devices that reproduce in vitro neuronal networks up to connectome-on-chip, enabling study of human organ physiology, drug effects, and molecular and functional mechanisms on neuronal circuits. Offerings include MEA-integrated devices for recording neural activity (developed with Axion BioSystems), UpLink software, and models such as innervated skin, pain-on-chip, and DuaLink for chemotherapy studies.

Who are Neurofluidics's competitors?

Neurofluidics's competitors and similar companies include Nalu Medical, Impel Pharmaceuticals, BlackThorn Therapeutics, Envoy Therapeutics, and Hypnion.

Where is Neurofluidics headquartered?

Neurofluidics is headquartered in United States.

How many employees does Neurofluidics have?

Neurofluidics has 1,000 employees 🔒.

When was Neurofluidics founded?

Neurofluidics was founded in 2010 🔒.

What sector and industry vertical is Neurofluidics in?

Neurofluidics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Neurofluidics

Who are the top strategic acquirers in Neurofluidics's sector and industry

Top strategic M&A buyers and acquirers in Neurofluidics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Neurofluidics?

Top strategic M&A buyers groups and sectors for Neurofluidics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Neurofluidics's sector and industry vertical

Which are the top PE firms investing in Neurofluidics's sector and industry vertical?

Top PE firms investing in Neurofluidics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Neurofluidics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Neurofluidics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Neurofluidics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Neurofluidics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Neurofluidics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Neurofluidics?

The key public trading comparables and valuation benchmarks for Neurofluidics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Neurofluidics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Neurofluidics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Neurofluidics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Neurofluidics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Neurofluidics's' sector and industry vertical?

Access recent funding rounds and capital raises in Neurofluidics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.